Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Adenocarcinoma × Telemedicine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Colorectal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Pain 2 Lung Neoplasms 2 Hematopoietic and Lymphatic System Neoplasm 2 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sedentary Behavior 1 Sarcoma 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Polyps 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Motor Activity 1 Metastatic Pancreatic Adenocarcinoma 1 Malignant Hepatobiliary Neoplasm 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Head and Neck Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

Radiotherapy 2 Radiosurgery 2 Urine Specimen Collection 1 Trastuzumab 1 Therapeutic Irrigation 1 Telemedicine 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Radiofrequency Ablation 1 Prostatectomy 1 Oxaliplatin 1 Narrow Band Imaging 1 Longitudinal Studies 1 Liquid Biopsy 1 Leuprolide 1 Esophagectomy 1 Endoscopy 1 Docetaxel 1 Diagnostic Imaging 1 Dashboard Systems 1 Capecitabine 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04667403 2022-04-28

PANTELO

Institut Cancerologie de l'Ouest

Phase NA Unknown

Adenocarcinoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡